特应性皮炎:TREATgermany登记中吸烟与非吸烟患者的疾病特征与共病比较
TREATgermany是一项德国非干预性临床登记,纳入中重度特应性皮炎(AD)患者,比较吸烟与非吸烟者的疾病特征和特应性共病。在908例报告吸烟状态的患者中,吸烟者渗液/结痂和抓痕强度及患者总体评估(PGA)更高,控制良好周数更少、瘙痒更重,总IgE更高且支气管哮喘初诊年龄更小;校正混杂后渗液/结痂增加、控制良好周数减少和瘙痒更重仍存在差异。
要点
- 吸烟的AD患者渗液/结痂和抓痕强度及PGA评分高于非吸烟者。
- 吸烟者控制良好周数更少、瘙痒更重,校正混杂后差异仍存在。
- 成人起病AD吸烟者足部受累机会为2.5倍。
核心结论
- 德国登记数据表明,吸烟的AD患者疾病负担更高,成人起病AD的皮损分布模式不同。
研究设计与样本
- TREATgermany是一项德国非干预性临床登记,纳入中重度AD患者。
- 分析2016年6月至2020年4月入组、德国39个中心的基线数据,比较吸烟者与非吸烟者的AD疾病特征和共病。
- 921例患者中908例报告吸烟状态,男性58.7%,平均年龄41.9±14.4岁。
主要发现
- 客观特应性皮炎评分(oSCORAD)在吸烟者(n=352;38.8%)与非吸烟者之间无差异。
- 吸烟者渗液/结痂和抓痕强度及患者总体评估(PGA)AD严重度评分高于非吸烟者。
- 吸烟者报告控制良好周数少于非吸烟者,瘙痒重于非吸烟者。
- 吸烟者总IgE水平更高,支气管哮喘初诊年龄更小。
- 校正潜在混杂因素后,渗液/结痂增加、控制良好周数减少和瘙痒更重仍在吸烟者与非吸烟者间存在差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a multifactorial genesis including genetic predispositions and environmental risk and trigger factors. One of the latter possibly is smoking, indicated by an increased prevalence of AD in adults and children that are actively or passively exposed to cigarette smoke. OBJECTIVES: In this study, AD characteristics and its atopic comorbidities are compared in smoking and non-smoking AD patients. METHODS: TREATgermany is a non-interventional clinical registry which includes patients with moderate to severe AD in Germany. Baseline data of patients included in TREATgermany from inception in June 2016 to April 2020 in 39 sites across Germany was analysed comparing AD disease characteristics and comorbidities in smokers vs. non-smokers. RESULTS: Of 921 patients, 908 (male: 58.7%) with a mean age of 41.9 ± 14.4 reported their smoking status. The objective Scoring of Atopic Dermatitis (oSCORAD) did not differ between smokers (n = 352; 38.8%) and non-smokers, however, lesions' intensity of oozing/crusts and excoriations as well as patient global assessment scores (PGA) of AD severity were higher in smoking as opposed to non-smoking patients. Smokers reported a lower number of weeks with well-controlled AD and more severe pruritus than non-smokers. Total IgE levels were more elevated in smokers and they displayed a younger age at the initial diagnosis of bronchial asthma. After adjustment for potential confounders, the increased intensity of oozing/crusts, the reduced number of weeks with well-controlled AD and the greater pruritus remained different in smokers compared to non-smokers. In addition, smoking patients with adult-onset AD showed a 2.5 times higher chance of involvement of the feet. CONCLUSIONS: German registry data indicate that AD patients who smoke have a higher disease burden with a different distribution pattern of lesions in adult-onset AD.
引用
- Pilz AC, Schielein MC, Schuster B, et al. Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry. J Eur Acad Dermatol Venereol. 2021. PMID: 34743344. doi:10.1111/jdv.17789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。